ES2094112T3 - Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs. - Google Patents

Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs.

Info

Publication number
ES2094112T3
ES2094112T3 ES88202248T ES88202248T ES2094112T3 ES 2094112 T3 ES2094112 T3 ES 2094112T3 ES 88202248 T ES88202248 T ES 88202248T ES 88202248 T ES88202248 T ES 88202248T ES 2094112 T3 ES2094112 T3 ES 2094112T3
Authority
ES
Spain
Prior art keywords
oligopeptides
sequence
diagnosis
crs
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88202248T
Other languages
English (en)
Inventor
Jaap Goudsmit
Robert Hans Meloen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting Centraal Diergeneeskundig Instituut
Academisch Ziekenhuis bij de Universiteit Van Amsterdam
Original Assignee
Stichting Centraal Diergeneeskundig Instituut
Academisch Ziekenhuis bij de Universiteit Van Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centraal Diergeneeskundig Instituut, Academisch Ziekenhuis bij de Universiteit Van Amsterdam filed Critical Stichting Centraal Diergeneeskundig Instituut
Application granted granted Critical
Publication of ES2094112T3 publication Critical patent/ES2094112T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A OLIGOPEPTIDOS QUE TIENEN UTILIDAD EN DIAGNOSIS Y VACUNACION FRENTE A DICHOS OLIGOPEPTIDOS. LOS OLIGOPEPTIDOS TIENEN UNA LONGITUD DE 8 A 17 AMINOACIDOS. LA SECUENCIA DE AMINOACIDOS CORRESPONDE A UNA SECUENCIA QUE OCURRE EN LA REGION V3 DE GP120 Y COMPRENDE LA SECUENCIA DE CONVERSION BETA GPC(R) EN LAS POSICIONES 312 - 314(315) O UNA SECUENCIA VARIANTE DE CONVERSION BETA, Y SECUENCIAS LATRALES DE AL MENOS UNO, Y PREFERIBLEMENTE AL MENOS DOS, AMINOACIDOS A AMBOS LADOS DE LA SECUENCIA DE CONVERSION BETA.
ES88202248T 1987-10-09 1988-10-07 Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs. Expired - Lifetime ES2094112T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702403A NL8702403A (nl) 1987-10-09 1987-10-09 Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Publications (1)

Publication Number Publication Date
ES2094112T3 true ES2094112T3 (es) 1997-01-16

Family

ID=19850727

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88202248T Expired - Lifetime ES2094112T3 (es) 1987-10-09 1988-10-07 Oligopeptidos y su uso para el diagnostico y vacunacion relacionados con el sida y el crs.

Country Status (8)

Country Link
EP (2) EP0311219B1 (es)
JP (1) JPH03501968A (es)
AT (1) ATE141287T1 (es)
CA (1) CA1340914C (es)
DE (1) DE3855471T2 (es)
ES (1) ES2094112T3 (es)
NL (1) NL8702403A (es)
WO (1) WO1989003391A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0328390B1 (en) * 1988-02-10 1994-09-14 Immulogic Pharmaceutical Corporation Peptide treatment of refractory infectious diseases
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0436634A1 (en) * 1988-10-03 1991-07-17 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
EP0448095A1 (en) * 1990-03-21 1991-09-25 Wolf, Hans Joachim, Prof. Dr. Subregion of the retroviral ENV protein, DNA sequences encoding it and compositions for the diagnosis, prevention or therapy of retrovirus infections
AU8228791A (en) * 1990-06-15 1992-01-07 New York University Heterohybridomas producing human monoclonal antibodies to hiv-1
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
CA2047031A1 (en) * 1990-07-19 1992-01-20 Stephen Marburg Peptide-polysaccharide-protein conjugate vaccines
CA2047073A1 (en) * 1990-07-19 1992-01-20 William J. Leanza Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
IL99077A0 (en) * 1990-08-13 1992-07-15 Merck & Co Inc New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
KR100220531B1 (ko) * 1990-08-22 1999-10-01 앤더스 발네 인간의 면역 결핍 바이러스 감염을 차단시키는 펩티드 및 그것의 사용 방법
EP0554401A4 (en) * 1990-10-26 1996-10-30 New York Health Res Inst Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
EP0492920A1 (en) * 1990-12-24 1992-07-01 Merck & Co. Inc. Chimaeric influenza-HIV vaccine
US6139843A (en) * 1991-04-02 2000-10-31 Albert Einstein College Of Medicine Of Yeshiva University Peptide compositions for the treatment of HIV
JPH0570493A (ja) * 1991-05-31 1993-03-23 Chemo Sero Therapeut Res Inst ヒト免疫不全ウイルス（ｈｉｖ）関連免疫調製物
GB9318901D0 (en) * 1993-09-13 1993-10-27 Centre Nat Rech Scient Multiple branch peptide construction
WO2009008888A1 (en) * 2007-07-10 2009-01-15 Matthias Rath African swine virus polypeptides as vaccines and its therapeutic use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US779431A (en) * 1903-06-02 1905-01-10 American Tobacco Co Cigarette-machine.
WO1986002383A1 (en) * 1984-10-18 1986-04-24 Institut Pasteur Envelope antigens of lymphadenopathy associated virus and their applications
WO1987002775A1 (en) * 1985-10-24 1987-05-07 Southwest Foundation For Biomedical Research Synthetic peptides and use for diagnosis and vaccination for aids and arc

Also Published As

Publication number Publication date
WO1989003391A1 (en) 1989-04-20
NL8702403A (nl) 1989-05-01
EP0311219A1 (en) 1989-04-12
CA1340914C (en) 2000-02-29
DE3855471T2 (de) 1996-12-19
EP0311219B1 (en) 1996-08-14
ATE141287T1 (de) 1996-08-15
JPH03501968A (ja) 1991-05-09
DE3855471D1 (de) 1996-09-19
EP0389489A1 (en) 1990-10-03

Similar Documents

Publication Publication Date Title
DK0415850T3 (da) Bivalente metalsalte af 2-N,N-di(carboxymethyl)-amino-3-cyano-4-carboxymethyl-5-carboxythiophensyre, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
DK383688A (da) 3-desmethyl-mevalonsyrederivater, deres fremstilling og anvendelse samt mellemprodukter ved fremstilling
CA2291994A1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
CY1110927T1 (el) Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων
DE3855471D1 (de) Oligopeptide und ihre Anwendung zu Diagnose- und Impfzwecken für AIDS und ARC
NO974104L (no) Faste diacyl-organiske peroksyd-dispersjoner
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
DK84888A (da) Neisseria gonorrhoea-lectin, anvendeligt som vaccine og diagnostisk markoer, og midler til fremstilling af dette lectin
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
DE3887014D1 (de) Nukleoside, ihre Herstellung und pharmazeutische Zusammenstellungen.
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
FI883643A0 (fi) Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna.
BR9506956A (pt) Composição farmacêutica antitussígena
DK103987D0 (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
ES542061A0 (es) Un procedimiento para la preparacion de (r)-4-amino-n-(1-fe-niletil)benzamida,(s)-4-amino-n-(1-feniletil)benzamida,o unasal de las mismas
FI874123A7 (fi) Heptanoyyli-Glu-Asp-Ala-aminohappo -immunostimulantti.
NO893727L (no) Stabile oksapenem-3-karboksylsyrer og deres anvendelse som beta-laktamasehemmere.
NO920143L (no) Substituerte 2-imidazoliner og fremstilling og anvendelsederav
DK513188D0 (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
NO901169D0 (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 311219

Country of ref document: ES